Bioptik Technology (4161) — Cash Flow Reinvestment Rate
Bioptik Technology (4161) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting NT$4.94 Million (capex NT$4.94 Million ) from operating cash flow of NT$53.21 Million. Explore Bioptik Technology capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bioptik Technology Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Bioptik Technology across 8 annual periods. Also explore Bioptik Technology (4161) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bioptik Technology (2017–2025)
Year-by-year capital reinvestment analysis for Bioptik Technology. For live market cap and broader valuation context, see how much is Bioptik Technology worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | NT$39.23 Million | NT$59.99 Million | NT$22.80 Million | ▲ +481.8% |
| 2024 | 0.11x | NT$17.85 Million | NT$158.82 Million | NT$15.51 Million | ▼ -61.1% |
| 2023 | 0.29x | NT$59.58 Million | NT$205.95 Million | NT$31.04 Million | ▼ -92.8% |
| 2022 | 4.02x | NT$221.24 Million | NT$55.06 Million | NT$17.08 Million | ▼ -80.0% |
| 2020 | 20.13x | NT$132.29 Million | NT$6.57 Million | NT$13.18 Million | ▲ +214.2% |
| 2019 | 6.40x | NT$262.81 Million | NT$41.03 Million | NT$27.42 Million | ▲ +77.1% |
| 2018 | 3.62x | NT$151.22 Million | NT$41.83 Million | NT$50.96 Million | ▼ -78.0% |
| 2017 | 16.46x | NT$181.43 Million | NT$11.02 Million | NT$62.72 Million | — |